Tag: CBT > DEA Rescheduling: Page 7

Cannabis Rescheduling

Cannabis Rescheduling Reactions Mixed: While Some Applaud Potential, Others Push For More

Executives, lawmakers and nonprofit leaders weigh in on the significance and shortcomings of the DEA's move to reclassify cannabis as a less dangerous substance.

May 1, 2024

Cannabis Rescheduling

UPDATE: DEA Moves to Reschedule Cannabis

The federal agency that has long enforced prohibition aligns with the recommendation from the U.S. Department of Health and Human Services, FDA to reclassify cannabis as a Schedule III substance under the Controlled Substances Act.

April 30, 2024

Cannabis Rescheduling

Cannabis Rescheduling Update: Is a ‘Notoriously Secretive Agency’ Now Involved?

A report that HHS requested an opinion from the Department of Justices’ Office of Legal Counsel raises new questions and concerns. Attorney Shane Pennington explains why that request and the outcome would be crucial to the schedule review process and the industry’s future.

April 29, 2024

Cannabis Rescheduling

21 US Lawmakers Express Frustration With DEA’s Inaction on Cannabis Rescheduling

The 11 senators and 10 House representatives urged for swift action to remove cannabis from a Schedule I listing in a new letter.

April 25, 2024

California

The State of Federal Cannabis Reform Leads CBT’s Most-Read Articles in April

4/20 deals and events, California tax defaults, and nationwide municipal opt outs also highlighted Cannabis Business Times’ most popular stories this month.

April 25, 2024

Legislation and Regulation

Federal Cannabis Legalization and Reform: Where Are We in 2024?

U.S. cannabis reform hasn’t come easy amid a divided Congress, but plenty of opportunities remain on the table for the remainder of the year.

April 20, 2024

Florida

The Future of Hemp-Derived Delta-9 THC Headlines CBT’s Most-Read Articles for March

Readers also dove headfirst into Amazon’s delta-8 problems and a potential rescheduling roadblock with the DEA’s five-factor test this month.

March 28, 2024

Cannabis Rescheduling

3 GOP Senators Tell DEA Not to Reschedule Cannabis

Led by former presidential candidate Mitt Romney, the senators argue rescheduling would violate an international treaty in letter to DEA administrator.

March 27, 2024

Cannabis Rescheduling

DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible

After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.

March 19, 2024

Cannabis Rescheduling

Biden 1st President to Mention ‘Marijuana’ During SOTU Since Reagan

Cannabis advocates clash on the significance of Biden’s call for cannabis reform during his 2024 State of the Union Address.

March 8, 2024

Cannabis Rescheduling

'Deschedule or Do Nothing:' Drug Policy Alliance Says Rescheduling Cannabis Would Not End Criminalization

Drug Policy Alliance and representatives from other cannabis organizations and businesses explained the limitations and potential harms of relisting cannabis as a Schedule III drug from Schedule I of the Controlled Substances Act in a special virtual press briefing.

March 1, 2024

Cannabis Business Financial Report

Trulieve Reports Receiving Refund For 280E Taxes Paid

The multistate cannabis company, as noted in its 2023 financial report and earnings call, says it received $113 million of the more than $174 million it requested in combined amended state and federal tax returns.

February 29, 2024